Herpesvirus reactivation is associated with mortality in critically ill ICU patients with COVID-19: Insights from a retrospective single-center analysis of 455 cases
PLOS One · 2026
DOI: 10.1371/journal.pone.0354153 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Stefanie Michel und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Intensive Care Medicine, University Hospital Essen, University of Duisburg-Essen, Hufelandstraße, Essen, Germany. Hauptthemen laut MEDLINE: COVID-19, Virus Activation, Herpesvirus 1, Human. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Intensivpflege
Abstract (Originalsprache)
Background
Critically ill patients with COVID-19 frequently develop viral reactivation, yet the clinical significance of herpes simplex virus type 1 (HSV-1) and cytomegalovirus (CMV) remains a matter of debate.
Methods
We conducted a retrospective single-center study of 455 consecutive intensive care unit (ICU) patients with confirmed SARS-CoV-2 infection between March 2020 and December 2021. Patients underwent screening for HSV-1 and CMV in whole blood and respiratory samples. A multivariable model was used to independently investigate risk factors associated with mortality.
Results
The mean age was 57 years (range: 13–94 years), and 316 (69%) were male. During a median ICU stay of 14 (0–90) days, viral reactivation (either HSV-1 or CMV or both) occurred in 164 (36%) patients. HSV-1 and CMV co-reactivation was detected in 57 (13%) patients, isolated HSV-1 reactivation was observed in 54 (12%) patients and isolated CMV reactivation in 53 (12%) patients. Median time from ICU admission to viral detection was 4 days, with a stepwise increase with longer ICU stay. Detection of HSV-1 was associated with decreased ICU survival (32% versus 67%; p < 0.001) which remained significant after multivariable adjustment. Detection of HSV-1 but not CMV was associated with an increased need for invasive mechanical ventilation, veno-venous extracorporeal membrane oxygenation therapy, and the need for renal replacement therapy. Higher neutrophil-lymphocyte ratios were independently associated with an increased risk of ICU mortality and correlated with detection of HSV-1 and CMV.
Conclusion
Herpesvirus reactivation was common in critically ill patients with COVID-19. HSV-1 reactivation was associated with a more severe course of disease and increased ICU mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Anesthesiology and Intensive Care Medicine, University Hospital Essen, University of Duisburg-Essen, Hufelandstraße, Essen, Germany.
- Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Hufelandstraße, Essen, Germany.
- Institute for Virology, University Hospital Essen, University of Duisburg-Essen, Hufelandstraße, Essen, Germany.
- Pharmacy, University Hospital Essen, University of Duisburg-Essen, Hufelandstraße, Essen, Germany.
ORCID-Profile: Bettina Budeus, Simon Dubler
Zitieren
APA
Michel, S., Kempf, C., Pirschtat, N., Herbstreit, F., Budeus, B., Voigt, S., Dedy, J., Brenner, T., & Dubler, S. (2026). Herpesvirus reactivation is associated with mortality in critically ill ICU patients with COVID-19: Insights from a retrospective single-center analysis of 455 cases. PLOS One. https://doi.org/10.1371/journal.pone.0354153
Vancouver
Michel S, Kempf C, Pirschtat N, Herbstreit F, Budeus B, Voigt S, et al. Herpesvirus reactivation is associated with mortality in critically ill ICU patients with COVID-19: Insights from a retrospective single-center analysis of 455 cases. PLOS One. 2026. doi:10.1371/journal.pone.0354153
BibTeX
@article{Michel2026,
author = {Michel, Stefanie and Kempf, Cilian and Pirschtat, Nina and Herbstreit, Frank and Budeus, Bettina and Voigt, Sebastian and Dedy, Jutta and Brenner, Thorsten and Dubler, Simon},
title = {Herpesvirus reactivation is associated with mortality in critically ill ICU patients with COVID-19: Insights from a retrospective single-center analysis of 455 cases},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0354153}
}
EUVIMED